The presence of ischemic perivascular lesions in the retina is significantly associated with atrial fibrillation, suggesting potential implications for early detection and management of this common cardiac arrhythmia.
March 2024
Results from a phase 2, randomized, placebo-controlled trial of TAK-994, a selective oral orexin receptor 2 agonist, in patients with type 1 narcolepsy are discussed, offering insights into potential new treatment options for this sleep disorder.
March 2024